Pharmax Research Clinic
Pharmax Research Clinic is dedicated to conducting clinical trials to develop and improve treatments for various diseases. They focus on helping find new treatments and/or improve existing ones through regulated FDA-approved studies, without requiring health insurance, Medicare, or PCP referrals. Their goal is to contribute to medical research while ensuring participant safety and providing professional service.
Industries
Nr. of Employees
small (1-50)
Pharmax Research Clinic
Flushing, New York, United States, North America
Products
RSV and hMPV VLP vaccine study (Study ID: D8610C00001)
A randomized study evaluating efficacy, immunogenicity and safety of an RSV and hMPV VLP vaccine versus placebo in participants aged 60 years and older; includes in-clinic visits and telephone follow-ups over a 24-month period.
Major Depressive Disorder studies (Study ID: 42847922MDD3003; 67953964MDD3005)
Interventional trials in adults assessing oral therapeutics for prevention of depressive relapse and treatment of MDD with comorbid insomnia; include multiple in-person visits and telephone follow-ups over ~22 weeks.
RSV and hMPV VLP vaccine study (Study ID: D8610C00001)
A randomized study evaluating efficacy, immunogenicity and safety of an RSV and hMPV VLP vaccine versus placebo in participants aged 60 years and older; includes in-clinic visits and telephone follow-ups over a 24-month period.
Major Depressive Disorder studies (Study ID: 42847922MDD3003; 67953964MDD3005)
Interventional trials in adults assessing oral therapeutics for prevention of depressive relapse and treatment of MDD with comorbid insomnia; include multiple in-person visits and telephone follow-ups over ~22 weeks.
Services
On-site conduct of Phase II-IV outpatient interventional clinical trials including participant visits, protocol execution, site monitoring and sponsor coordination.
Recruitment outreach, telephone pre-screening assessments, application intake and enrollment coordination to identify eligible study volunteers.
On-site sample processing using centrifuges with multi-temperature storage (-20°C, -45°C, -86°C) and computerized temperature recording for sample integrity and investigational product storage.
Support for informed consent procedures, safety monitoring during trials, and processes consistent with GCP, IRB/Ethics Committee oversight and regulatory reporting.
On-site conduct of Phase II-IV outpatient interventional clinical trials including participant visits, protocol execution, site monitoring and sponsor coordination.
Recruitment outreach, telephone pre-screening assessments, application intake and enrollment coordination to identify eligible study volunteers.
On-site sample processing using centrifuges with multi-temperature storage (-20°C, -45°C, -86°C) and computerized temperature recording for sample integrity and investigational product storage.
Support for informed consent procedures, safety monitoring during trials, and processes consistent with GCP, IRB/Ethics Committee oversight and regulatory reporting.
Expertise Areas
- Clinical trial management
- Participant recruitment and retention
- Vaccine clinical trials
- Psychiatric clinical trials
Key Technologies
- Ultra-low temperature storage (-86°C)
- Refrigerated and room-temperature centrifugation
- Computerized temperature monitoring systems
- Electrocardiography (ECG)
News & Updates
A study to evaluate the efficacy, immunogenicity, and safety of an RSV and hMPV VLP vaccine compared with placebo in participants aged 60 years of age and older, lasting 24 months with 3 in-clinic visits and 4 telephone calls.
A study of oral Aticaprant plus an oral antidepressant to prevent return of depression symptoms in participants with Major Depressive Disorder, lasting 22 weeks with 12 in person visits and 3 telephone calls.
Adult and elderly patients with Major Depressive Disorder and Insomnia Symptoms, lasting 22 weeks with 26 in-person visits and 5 telephone calls.
Starts on January 6, 2025, Study ID No.: D8610C00001.
A study to evaluate the efficacy, immunogenicity, and safety of an RSV and hMPV VLP vaccine compared with placebo in participants aged 60 years of age and older, lasting 24 months with 3 in-clinic visits and 4 telephone calls.
A study of oral Aticaprant plus an oral antidepressant to prevent return of depression symptoms in participants with Major Depressive Disorder, lasting 22 weeks with 12 in person visits and 3 telephone calls.
Adult and elderly patients with Major Depressive Disorder and Insomnia Symptoms, lasting 22 weeks with 26 in-person visits and 5 telephone calls.
Starts on January 6, 2025, Study ID No.: D8610C00001.